Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 8

Zeitschriftenartikel

Kaiser, Lena; Quach, S.; Zounek, A. J.; Wiestler, B.; Zatcepin, A.; Holzgreve, A.; Bollenbacher, A.; Bartos, L. M.; Ruf, V. C.; Boening, G.; Thon, N.; Herms, J.; Riemenschneider, M. J.; Stoecklein, S.; Brendel, M.; Rupprecht, R.; Tonn, J. C.; Bartenstein, P.; von Baumgarten, L.; Ziegler, S. und Albert, N. L. (2024): Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET. In: European Journal of Nuclear Medicine and Molecular Imaging [PDF, 1MB]

Unterrainer, M.; Fleischmann, D. F.; Vettermann, F.; Ruf, V.; Kaiser, L.; Nelwan, D.; Lindner, S.; Brendel, M.; Wenter, V.; Stoecklein, S.; Herms, J.; Milenkovic, V. M.; Rupprecht, R.; Tonn, J. C.; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2020): TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-18-GE-180 PET study. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 6: S. 1368-1380

Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2019): A look ahead: future directions of SSR-directed imaging and therapy in meningioma. In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362

Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2019): Current status of SSR-directed imaging and therapy in meningioma. In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180

Binder, H.; Willscher, E.; Löffler-Wirth, H.; Hopp, L.; Jones, D. T. W.; Pfister, S. M.; Kreuz, M.; Gramatzki, D.; Fortenbacher, E.; Hentschel, B.; Tatagiba, M.; Herrlinger, U.; Vatter, H.; Matschke, J.; Westphal, M.; Krex, D.; Schackert, G.; Tonn, J. C.; Schlegel, U.; Steiger, H. -J.; Wick, W.; Weber, R. G.; Weller, M. und Löffler, M. (2019): DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development. In: Acta Neuropathologica Communications, Bd. 7, 59

Unterrainer, Marcus; Fleischmann, D. F.; Diekmann, C.; Vomacka, L.; Lindner, S.; Vettermann, F.; Brendel, M.; Wenter, V.; Ertl-Wagner, B.; Herms, J.; Wetzel, C.; Rupprecht, R.; Tonn, J. C.; Belka, C.; Bartenstein, P.; Niyazi, M. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2019): Comparison of F-18-GE-180 and dynamic F-18-FET PET in high grade glioma: a double-tracer pilot study. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 3: S. 580-590

Unterrainer, M.; Winkelmann, I.; Suchorska, B.; Giese, A.; Wenter, V.; Kreth, F. W.; Herms, J.; Bartenstein, P.; Tonn, J. C. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2018): Biological tumour volumes of gliomas in early and standard 20-40 min F-18-FET PET images differ according to IDH mutation status. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 7: S. 1242-1249

Gramatzki, D.; Kickingereder, P.; Hentschel, B.; Schramm, J.; Tonn, J. C.; Schackert, G.; Reifenberger, G.; Löffler, M.; Bendszus, M. und Weller, M. (2016): Extended temozolomide for newly diagnosed glioblastoma: an analysis of the German Glioma Network. In: Neuro-Oncology, Bd. 18: S. 47

Diese Liste wurde am Sat Nov 23 21:36:47 2024 CET erstellt.